FOR IMMEDIATE RELEASE
inSeption Group Named One of the Philadelphia Region’s Fastest-Growing Private Companies by the Philadelphia100®
[Audubon, PA – October 13 2025] — inSeption is proud to announce that it has been named among the Philadelphia100®, the prestigious recognition awarded to the fastest growing privately held companies in the Greater Philadelphia region. This distinction highlights inSeption’s sustained revenue growth, operational excellence, and continued impact in the region’s economy.
The Philadelphia100® is a merit-based program that honors companies that have shown strong three-year average revenue growth, started with at least $250,000 in revenue in the earliest reported year, and are privately held.
The rigorous evaluation and validation of financials—audited in partnership with Kreischer Miller—makes this award one of the region’s most respected growth benchmarks.
“Being named to the Philadelphia100® is a reflection of what’s possible when you stay true to your principles and your people,” said Joseph Arcangelo, Co-Founder and Managing Partner of inSeption Group. “From day one, inSeption has focused on creating a culture of integrity, collaboration, and purpose — and this recognition proves that success naturally follows when you get those things right.”
“This honor represents more than growth; it represents consistency, trust, and a shared belief in doing things differently. Our team’s commitment to excellence and authenticity continues to drive our momentum, and we’re proud to be part of a community that celebrates innovation and hard work in Philadelphia.” Said Brian Sulpizio, Co-Founder and Managing Partner
Looking Ahead
This recognition comes at an exciting time for inSeption, as the organization accelerates into its next chapter of growth — one defined by purpose, partnership, and progress.
With a commitment to redefine what collaboration in clinical outsourcing can look like, inSeption’s focus remains sharp on:
- Driving success in complex clinical programs through unmatched expertise and a uniquely engaged team approach
- Building powerful partnerships with emerging and midsized biotechs that value trust, transparency, and shared accountability
- Shaping strategy and innovation with insight from inSeption’s inaugural Scientific Advisory Board
Fueled by the momentum of this honor, inSeption continues to expand its impact — not just in the marketplace, but in the way meaningful work gets done.
About Philadelphia100®
Launched to celebrate entrepreneurial growth across the region, the Philadelphia100® honors 100 privately held companies that exhibit exceptional revenue growth. The program’s mission is to spotlight and support the region’s fastest-growing businesses, thereby reinforcing economic vitality, spreading success stories, and fostering peer learning.
The award recipients are recognized at an annual gala, and the event also offers networking and exposure opportunities for leaders in the local business community.
This year’s award ceremony will be held November 13, 2025, at Live! Casino & Hotel Philadelphia.
About inSeption Group
inSeption Group is a clinical outsourcing organization supporting sponsors in drug development and regulatory submissions through expert-led teams and a model that prioritizes quality, agility, and deep scientific engagement. With extensive experience in complex therapeutic areas and a strong culture of ownership and integrity, inSeption delivers solutions that consistently exceed expectations.
For media inquiries, contact:
Kristin Morris
Senior Director, Corporate Communications
267-397-8980
kmorris@inseptiongroup.com
inseptiongroup.com